arrow
S

Steven H. Lin

The University of Texas MD Anderson Cancer Center
H指数:71
被引数:1.9万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Using Induction Chemoimmunotherapy as a Bridge to Definitive Local Therapy for Non-Metastatic NSCLC: Real-World Outcomes From a Comprehensive Cancer Center

使用诱导化免疗法作为非转移性NSCLC患者接受根治性局部治疗的桥梁:来自综合癌症中心的真实世界结果

2026-09-010
PRE
Long-term outcomes after proton therapy vs. intensity-modulated photon radiotherapy with concurrent chemotherapy for locally advanced non-small-cell lung cancer: post-hoc analysis of a prospective randomized trial

局部晚期非小细胞肺癌患者接受质子治疗与调强光子放射治疗联合同步化疗的长期预后比较:前瞻性随机试验的事后分析

2026-05-210
PRE
Initial Evaluation of Feasibility and Cutaneous Toxicity of Electron FLASH Radiotherapy Using a Standard-of-Care Fractionation Scheme in a Porcine Skin Model

使用标准护理分割方案在猪皮肤模型中对电子FLASH放射治疗的可行性和皮肤毒性进行初步评估

Cancers
IF4.4
2026-04-030
OAAI
EGFR mutation status, treatment patterns, and outcomes in resectable early-stage non-small cell lung cancer prior to adjuvant EGFR-TKI approval: An international real-world study

EGFR突变状态、治疗模式及辅助EGFR-TKI批准前的可切除早期非小细胞肺癌的结局:一项国际真实世界研究

2026-02-280
PRE
Pretreatment Risk Model for Radiation-Induced Lymphopenia Is Associated With Adjuvant Durvalumab Efficacy in Patients With Unresectable Stage III NSCLC

不可切除III期NSCLC患者中,辐射诱导淋巴细胞减少的预处理风险模型与辅助度伐利尤单抗疗效相关

2026-02-260
OAAI
Bayesian Learning to Reduce Cardiac Risk for Locally Advanced NSCLC Patients Based on Personalized Radiotherapy Prescription

基于个性化放疗方案,利用贝叶斯学习降低局部晚期NSCLC患者的心脏风险

2025-12-070
PRE
SHP2: A Redox-Sensitive Regulator Linking Immune Checkpoint Inhibitor Therapy to Cancer Treatment and Vascular Risk

SHP2:连接免疫检查点抑制剂疗法、癌症治疗与血管风险的氧化还原敏感性调节因子

2025-11-210
OAAI
SARS-CoV-2 mRNA vaccines sensitize tumours to immune checkpoint blockade

SARS-CoV-2 mRNA疫苗使肿瘤对免疫检查点阻断敏感

Nature
IF48.5
2025-10-220
OAAI
Mutation testing, treatment patterns, and outcomes in patients with unresectable stage III EGFR-mutated non-small cell lung cancer treated with chemoradiotherapy: Final analysis of a global real–world study

不可切除的III期EGFR突变非小细胞肺癌患者接受放化疗的突变检测、治疗模式与结局:一项全球真实世界研究的最终分析

2025-09-080
PREAI
Plinabulin following radiation enhances dendritic cell maturation and checkpoint inhibitor retreatment of relapsed/refractory cancers

普林巴鲁林在放射治疗后可增强树突状细胞成熟,并改善复发/难治性癌症的检查点抑制剂再治疗。

Med
IF11.8
2025-06-270
PRE
Impacts of Radiation on Metabolism and Vascular Cell Senescence

辐射对代谢和血管细胞衰老的影响

2025-04-160
PRE
Radiotherapy promotes cuproptosis and synergizes with cuproptosis inducers to overcome tumor radioresistance

放射疗法促进铜死亡,并与铜死亡诱导剂协同作用以克服肿瘤放射抗性

2025-04-100
OA
Rapid Intracranial Response With Tarlatamab in Patients With Untreated Brain Metastases From SCLC—A Real-World Case Series: Case Report

达拉他单抗在未经治疗的SCLC脑转移患者中快速颅内应答——真实世界病例系列:病例报告

2025-03-240
PRE